Literature DB >> 23296657

Detection of the senescence-associated secretory phenotype (SASP).

Francis Rodier1.   

Abstract

Cellular senescence suppresses cancer by eliminating potentially oncogenic cells, participates in tissue repair, contributes to cancer therapy, and promotes organismal aging. Numerous activities of senescent cells depend on the aptitude of these cells to secrete myriads of bioactive molecules, a behavior termed the senescence-associated secretory phenotype (SASP). The SASP supports cell-autonomous functions like the senescence-associated growth arrest, and mediates paracrine interactions between senescent cells and their surrounding microenvironment. The biological functions and the regulation of the SASP are beginning to emerge, and current SASP assessment techniques include the analysis of SASP factors at the mRNA level, the direct measurement of factors inside or outside the cell (i.e., secreted), and the detection of SASP-provoked cellular responses. Here, we focus on a simple approach to collect SASP-conditioned media in order to directly measure secreted SASP factors using sandwich enzyme-linked immunosorbent assay. As an example, we discuss the assessment of the major SASP factor interleukin-6 in senescent human fibroblasts. Supplemental notes are provided to easily adapt this procedure to other SASP factors, change cell types, or scale the techniques for different volumes or high-throughput measurements. These techniques should facilitate the discovery of novel functions and regulators of the SASP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296657     DOI: 10.1007/978-1-62703-239-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

Review 1.  The Immortal Senescence.

Authors:  Anna Bianchi-Smiraglia; Brittany C Lipchick; Mikhail A Nikiforov
Journal:  Methods Mol Biol       Date:  2017

2.  Techniques to Induce and Quantify Cellular Senescence.

Authors:  Nicole Noren Hooten; Michele K Evans
Journal:  J Vis Exp       Date:  2017-05-01       Impact factor: 1.355

3.  Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Authors:  M Cioce; F Ganci; V Canu; A Sacconi; F Mori; C Canino; E Korita; B Casini; G Alessandrini; A Cambria; M A Carosi; R Blandino; V Panebianco; F Facciolo; P Visca; S Volinia; P Muti; S Strano; C M Croce; H I Pass; G Blandino
Journal:  Oncogene       Date:  2013-11-18       Impact factor: 9.867

4.  Non-canonical ATM/MRN activities temporally define the senescence secretory program.

Authors:  Nicolas Malaquin; Marc-Alexandre Olivier; Aurélie Martinez; Stéphanie Nadeau; Christina Sawchyn; Jean-Philippe Coppé; Guillaume Cardin; Frédérick A Mallette; Judith Campisi; Francis Rodier
Journal:  EMBO Rep       Date:  2020-08-12       Impact factor: 8.807

5.  Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage.

Authors:  Nicholas Rymut; Justin Heinz; Sudeshna Sadhu; Zeinab Hosseini; Colin O Riley; Michael Marinello; Jackson Maloney; Katherine C MacNamara; Matthew Spite; Gabrielle Fredman
Journal:  FASEB J       Date:  2019-11-26       Impact factor: 5.191

6.  Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer.

Authors:  R K Bikkavilli; S Avasarala; M Van Scoyk; J Arcaroli; C Brzezinski; W Zhang; M G Edwards; M K K Rathinam; T Zhou; J Tauler; S Borowicz; Y A Lussier; B A Parr; C D Cool; R A Winn
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 7.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

8.  Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.

Authors:  João Ramalho-Carvalho; Inês Graça; Antonio Gomez; Jorge Oliveira; Rui Henrique; Manel Esteller; Carmen Jerónimo
Journal:  J Hematol Oncol       Date:  2017-02-06       Impact factor: 17.388

9.  DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.

Authors:  Nicolas Malaquin; Arthur Vancayseele; Sophie Gilbert; Laureen Antenor-Habazac; Marc-Alexandre Olivier; Zakia Ait Ali Brahem; Fred Saad; Guila Delouya; Francis Rodier
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

10.  Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.

Authors:  Zehua Wang; Jianwen Gao; Yuko Ohno; Haiou Liu; Congjian Xu
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-06       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.